MHRA26 Mar 2026
Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17
The Medicines and Healthcare products Regulatory Agency published a recall notice for Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17 on 26 Mar 2026. It is one of 17 notices of this kind from MHRA since 26 Mar 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Medicines and Healthcare products Regulatory Agency
- Issued
- 14:01, 26 Mar 2026
- Alert class
- Class 4 Recall
- Official source
- Medicines and Healthcare products Regulatory Agency: the notice at its source
The latest from the MHRAEvery warning and recall in the United Kingdom
Source: Medicines and Healthcare products Regulatory Agency: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains public sector information licensed under the Open Government Licence v3.0.
The notice as issued
Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information.
Source: Medicines and Healthcare products Regulatory Agency: the notice at its source. The text is the agency's, unedited. Contains public sector information licensed under the Open Government Licence v3.0.